Mathematical modeling predicts synergistic antitumor effects of combining a macrophage-based, hypoxia-targeted gene
Markus R Owen1, I Johanna Stamper, Munitta Muthana
1Centre for Mathematical Medicine and Biology, School of Mathematical Sciences, University of Nottingham, Nottingham, UK. Markus.Owen@nottingham.ac.uk
Abstract:
Tumor hypoxia is associated with low rates of cell proliferation and poor drug delivery, limiting the efficacy of many conventional therapies such as chemotherapy. Because many macrophages accumulate in hypoxic regions of tumors, one way to target tumor cells in these regions could be to use genetically engineered macrophages that express therapeutic genes when exposed to hypoxia. Systemic delivery of such therapeutic macrophages may also be enhanced by preloading them with nanomagnets and applying a magnetic field to the tumor site. Here, we use a new mathematical model to compare the effects of conventional cyclophosphamide therapy with those induced when macrophages are used to deliver hypoxia-inducible cytochrome P450 to locally activate cyclophosphamide. Our mathematical model describes the spatiotemporal dynamics of vascular tumor growth and treats cells as distinct entities. Model simulations predict that combining conventional and macrophage-based therapies would be synergistic, producing greater antitumor effects than the additive effects of each form of therapy. We find that timing is crucial in this combined approach with efficacy being greatest when the macrophage-based, hypoxia-targeted therapy is administered shortly before or concurrently with chemotherapy. Last, we show that therapy with genetically engineered macrophages is markedly enhanced by using the magnetic approach described above, and that this enhancement depends mainly on the strength of the applied field, rather than its direction. This insight may be important in the treatment of nonsuperficial tumors, where generating a specific orientation of a magnetic field may prove difficult. In conclusion, we demonstrate that mathematical modeling can be used to design and maximize the efficacy of combined therapeutic approaches in cancer.
Insights
Engineered macrophages deliver targeted cancer therapy to hypoxic tumors. Combining this with chemotherapy and magnetic guidance enhances treatment efficacy, especially for deep tumors.
Area of Science:
- Oncology
- Biotechnology
- Mathematical Modeling
Background:
- Tumor hypoxia limits conventional cancer therapies like chemotherapy due to reduced cell proliferation and drug delivery.
- Macrophages naturally accumulate in hypoxic tumor regions, presenting an opportunity for targeted drug delivery.
- Genetically engineered macrophages can be designed to activate therapeutic genes specifically in hypoxic environments.
Purpose of the Study:
- To compare conventional cyclophosphamide therapy with a novel approach using engineered macrophages to deliver hypoxia-inducible cytochrome P450 for local drug activation.
- To investigate the synergistic effects of combining conventional chemotherapy with macrophage-based, hypoxia-targeted therapy.
- To evaluate the impact of magnetic guidance on the efficacy of engineered macrophage delivery.
Main Methods:
- Development and application of a novel mathematical model simulating tumor growth dynamics and cellular interactions.
- Simulation of conventional chemotherapy versus engineered macrophage-mediated local drug activation.
- Analysis of therapeutic efficacy under different administration timings and magnetic field parameters.
Main Results:
- Model simulations predict synergistic antitumor effects when combining conventional chemotherapy with engineered macrophage therapy, exceeding additive effects.
- Optimal efficacy is achieved when macrophage-based therapy is administered shortly before or concurrently with chemotherapy.
- Magnetic guidance significantly enhances engineered macrophage therapy, with efficacy primarily dependent on magnetic field strength, not direction.
Conclusions:
- Mathematical modeling is a valuable tool for designing and optimizing combined cancer therapeutic strategies.
- Engineered macrophages offer a promising approach for targeted cancer therapy in hypoxic tumor regions.
- Magnetic targeting of engineered macrophages presents a significant advancement for enhancing cancer treatment, particularly for non-superficial tumors.
Related Concept Videos
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...